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rBSC1 and enhanced countercurrent multiplication.
Background. A close association between the expression of
the sodium transporter, rat bumetanide sensitive cotransporter
(rBSC), in thick ascending limb of Henle and urinary concen-
tration has been reported. However, direct evidence for this
association and the mechanism of rBSC1 expression are still
to be elucidated.
Methods. Brattleboro (BB) rats weighing approximately 200
g were dehydrated by water restriction for 4 hours, which induced
around a 5% body weight reduction. Although plasma arginine
vasopressin (AVP) was undetectable even after the water restric-
tion, BB rats concentrated urine from 182  23 (mean  SD)
at baseline to 404  65 mOsm/kg · H2O.
Results. Urinary volume was reduced from 5.8  1.8 to 1.4 
0.6 mL/h. This treatment significantly increased sodium and urea
accumulation in the renal medulla and reduced urinary sodium
excretion. rBSC1 signals for both mRNA and protein were in-
creased in dehydrated rats, although aquaporin type 2 (AQP2)
expression was not enhanced in dehydrated BB rats. Subcuta-
neous infusion of desmopressin acetate (DDAVP) intensified
rBSC1 signals of BB rats more than those in dehydrated condition.
Conclusion. Dehydration increased rBSC1 expression and
enhanced countercurrent multiplication even in AVP defi-
ciency. These results supply strong evidence for the association
between rBSC1 expression and urinary concentration, and indi-
cate the presence of an AVP-independent mechanism for urine
concentration.
One of the main features of renal homeostatic mecha-
nisms is the maintenance of body fluid. In the thick as-
cending limb of Henle (TAL), NaCl is supplied through
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the kidney-specific sodium cotransporter, bumetanide
sensitive cotransporter (BSC1), to enrich the medullary
interstitial osmolality [1, 2]. In harmony with the apical
expression of water channels aquaporin type 2 (AQP2)
and urea transporters in collecting duct, final urinary con-
centration is determined [3–9]. To date, the association
between AQP2 expression and arginine vasopressin
(AVP) stimuli has been well established [3–8], explaining
the most part of physiologic mechanisms for renal uri-
nary concentration.
Enhanced expression of rat BSC1 (rBSC1) has been
also noted when the urine was highly concentrated [10–12],
and Kim et al [10] have directly demonstrated the effect
of exogenous or endogenous vasopressin on this trans-
porter expression. In addition, rats with limited rBSC1,
such as a rat with kidney isograft [12] and a rat with
chronic renal failure [13], failed to concentrate urine.
However, a high expression of this transporter in heart
disease [14], in which the expression of AQP2 remained
unaltered, suggests the presence of regulatory mecha-
nisms of rBSC1 other than an AVP-dependent system.
Fernandez-Llama et al [15] reported the inhibitory effect
of cyclooxygenase on rBSC1 expression, and Klein et al
[16] also reported the coincidence of impaired urinary
concentration and reduced transporter proteins, includ-
ing BSC1 in mice conserving AQP2 expression but lack-
ing tissue angiotensin converting enzyme (ACE) activity.
These findings suggest the presence of other mechanisms
regulating rBSC1 expression than those regulating AQP2.
Previous studies using the rats with congenital defects
in AVP production (Brattleboro rats; BB rats) demon-
strated the urinary concentration even in these rats under
the dehydrated condition [17, 18]. Possibly, AVP defi-
ciency may reveal the rBSC1 expression by mechanisms
other than AVP stimuli. Although Chou et al [19, 20]
demonstrated the altered water permeability induced by
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oxytocin in collecting ducts of BB rats, increased rBSC1
in thick ascending limb of Henle may also contribute
to urinary concentration by enhancing countercurrent
multipliers. Therefore, the present study was designed
to investigate dehydrated BB rats and focus on rBSC1
expression. Our results provided strong evidence for as-
sociation between expressional regulation of rBSC1 and
renal urinary concentration, as well as novel insight into
the mechanisms of rBSC1 expression.
METHODS
Experimental protocol
Brattleboro (BB) rats weighing around 200 g were
used for the experiments. These rats were catheterized
as described previously [21]. Briefly, catheters filled with
heparinized (100 U/mL) 0.9% NaCl were placed in the
femoral artery and vein. Each rat was housed in a sepa-
rate cage and provided with water containing 5% dex-
trose to ensure adequate postoperative hydration. The
following day, after urine collection for 1 hour, a 3 mL
blood sample was withdrawn, which was replaced with
a simultaneous injection of an equal volume of rat donor
blood. Then, rats were deprived of water for 4 hours,
and urine was collected every hour. Another 3 mL blood
sample was withdrawn from each treated rat, and then
each rat was deeply anesthetized and the kidneys were
removed for RNA and protein extraction, and for the
measurement of tissue electrolytes as reported pre-
viously [22]. Briefly, samples from the right kidney were
homogenized in 4 mol/L guanidine with 25 mmol/L so-
dium citrate and 0.7% mercaptoethanol for RNA extrac-
tion; those samples from the left kidney were homoge-
nized in 2 mL of phosphate-buffered saline (PBS), 1%
Triton, 1% deoxycholate, 0.1% sodium dodecyl sulfate
(SDS), and 0.1 mmol/L phenylmethylsulfonyl fluoride
(PMSF) for protein extraction. In other rats, renal whole
medullas were separated, put in microcentrifuge tubes,
and quickly weighed. The tubes were then plunged into
an 80C water bath for 60 minutes to inactivate enzymes.
The tubes were dried in an oven at 80C for 48 hours
and reweighed after the tissue had attained completely
dryness. Distilled water was then added and the bottles
were plunged into a water bath at 80C for 2 hours to
facilitate extraction of ions and urea into water. The
tubes were cooled to room temperature and reweighed
to determine the volume of added water. The superna-
tant after extraction was analyzed by an autoanalyzer.
The sodium, potassium, and urea concentrations were
expressed per kilogram of tissue weight.
Six control BB rats without water restriction and an-
other 6 BB rats with subcutaneous DDAVP (Kyowa-
Hakko, Tokyo, Japan) infusion (25 ng/hour/kg for 3 days
by osmotic pump) (alzet model 2002; Alza, Palo Alto,
CA, USA) were used for RNA and protein extraction.
Since subpicomolar plasma AVP may show physiologic
effects [23, 24], especially in dehydrated condition, an
additional 12 BB rats were included in the present study,
and their AVP V2 receptor activity was blocked by an
administration of orally active V2 receptor antagonist
OPC-31260, 10 mg/kg/day for 3 days (Otsuka Pharceuti-
cal Co., Ltd., Tokushima, Japan). Then, 6 of the rats
underwent water restriction, and rBSC1 protein signals
of all 12 rats were examined. The experimental protocol
was approved by the Ethics Committee for Animal Ex-
perimentation at Tohoku University.
Western blots
Immunoblotting using specific antibody against rBSC1
and AQP2 was performed as previously described [12, 21].
Briefly, the renal outer medulla or inner medulla was
homogenized in 2 mL of PBS, 1% Triton, 1% deoxycho-
late, 0.1% SDS, and 0.1 mmol/L PMSF. One hundred g
of protein in each lane was loaded in Laemmli SDS-
polyacrylamide gel electrophoresis (PAGE) (8 or 12%)
and transferred to a polyvinylidene difluoride membrane.
The membrane was blocked for 1 hour and exposed to
antibody diluted in 2.5% milk powder/[10 mmol/L Tris-
HCl, pH 8.5, 150 mmol/L NaCl, and 0.1% Tween 20
(TBST)] overnight at 4C and then to a second antibody
(peroxidase-linked anti-rabbit immoglobulin) for 1 hour
at room temperature. After washing, antigen-antibody
complexes were visualized with a chemiluminescence
system (ECL Plus, Amersham Bioscience, Piscataway,
NJ, USA).
Competitive PCR
Competitive polymerase chain reaction (PCR) analy-
sis for rBSC1 and AQP2 was performed as described
previously [14, 21]. Briefly, a point mutation for the for-
mation of EcoRI site was induced in the middle of a 352
bp of partial fragment for the kidney-specific sodium
cotransporter (rBSC1) cDNA. For AQP2, a pair of PCR
primers was designed to frame the major part of AQP2
cDNA (760 bp). By deleting 180 bp, a smaller product
(580 bp) was used to mimic cDNA for competitive PCR.
A series of diluted mimic cDNA was mixed with the
same amount of sample template cDNA (from 0.05 g
RNA) from each part of the kidney. PCR was performed
using 25 cycles. Following agarose gel electrophoresis,
the intensity of the bands in each sample, and those of
mimic cDNA, was measured using a densitometer. The
amount of mRNA in the sample was calculated from
the equivalent point.
Measurements of AVP
Arginine vasopressin (AVP) was measured by radio-
immunoassay (RIA) as described previously [11]. Briefly,
AVP was extracted using octacasyl-silane packed in a
cartridge (Sep-Pak C18 cartridge; Waters Associates,
Milford, MA, USA) and assayed using specific antibod-
ies to AVP (Mitsubishi Petrochemical, Tokyo, Japan).
The recovery rate was 72.4  6.8% (N  30).
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Change in the body weight % — 5.11.3
Plasma
Osmolality mOsm/kg · H2O 290.37.1 309.16.5a
Sodium mEq/L 142.13.0 151.92.2a
Potassium mEq/L 4.60.3 3.90.3a
Urea mg/dL 10.11.5 12.42.7
Creatinine mg/dL 0.510.12 0.510.10
AVP pg/mL ND ND
Urine
Volume mL/hour 5.81.8 1.40.6a
Osmolality mOsm/kg · H2O 18223 40465a
Abbreviations are: AVP, arginine vasopressin; ND, not detectable. Values
are meanSD.
aP  0.05 compared with euhydration
Other measurements and statistical analysis
Plasma and urinary osmolality was determined using
an osmometer (model 3D2; Advanced Instruments, Need-
ham Heights, MA, USA). Creatinine, urea, and electro-
lytes in plasma, urine, and supernatant of extraction were
measured by an autoanalyzer. Differences between phys-
iologic and laboratory data were examined for statistical
significance using paired and unpaired t tests followed
by the Student t test. The results are expressed as mean
SD. A P value 0.05 was considered significant.
RESULTS
Changes in urinalysis and plasma parameters
Table 1 demonstrates the physiologic reactions to wa-
ter restriction. Reduction in body weight and significant
elevation in plasma osmolality indicate the physiologic
condition of dehydration in rats with water restriction.
This treatment resulted in a significant increase in uri-
nary osmolality and a decrease in urine volume, although
plasma AVP level was less than detectable. This treat-
ment also markedly elevated plasma sodium concentra-
tion, whereas plasma urea was statistically unaltered.
In urinalysis, urinary sodium excretion was markedly
reduced, and urine potassium and urea were also signifi-
cantly decreased. Although administration of AVP V2
antagonist OPC-31260 for 3 days further lowered urine
osmolality from 190  39 to 128  19 mOsm/kg · H2O,
4 hour water restriction elevated urinary osmolality to
425  67 and decreased urine volume from 12.9  1.7
to 1.5  0.5 mL/hr, confirming almost the same level of
urine concentration.
Electrolyte and urea accumulation in renal medulla
Figure 1 shows the electrolytes and urea accumulations
in the renal medulla in BB rats with or without dehydra-
tion. Although level of potassium was unaltered, dehy-
dration significantly increased accumulation of sodium
and urea in renal medulla.
Fig. 1. (A ) Sodium, (B ) potassium, and (C ) urea accumulation in the
renal medulla. Data represent the mean  SD of 6 determinations in
each condition. *P  0.05.
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Fig. 2. Rat bumetanide sensitive cotransporter (rBSC) 1 expression.
(A ) Immunoblotting of rBSC1. The amount of protein loaded in each
lane is 100 g. (B ) Competitive polymerase chain reaction (PCR) of
rBSC1. Data represent the mean  SD of 6 determinations in each
condition. *P  0.05.
Changes in expression level of rBSC1
The results of Western blots of rBSC1 in the outer
medulla are demonstrated in Figure 2A, representing
the increased intensity of the protein signals in rats with
water restriction. Since Kim et al [10] have demonstrated
the increase in rBSC1 protein in response to AVP stim-
uli, rBSC1 bands of the outer medulla from BB rats
with subcutaneous AVP infusion, in which urine was
concentrated to 1440  68, are shown together. The
results demonstrate that further enhancement in the
band intensity was noted in these AVP infused rats.
Competitive PCR demonstrates that rBSC1 transcripts
in 1 g of total RNA was significantly higher in BB rats
with water restriction when compared to that in control
rats (Fig. 2B). To further confirm the AVP-independent
expression of rBSC1, protein signals of rats with OPC-
31260 were examined as demonstrated in Figure 3.
Again, signals are intensified in water-restricted rats (Fig.
3A). The statistical significance between control rats and
rats with dehydration was confirmed by the measure-
ment of signal density (Fig. 3B).
Changes in expression level of AQP2
The expression of AQP2 in BB rats with or without
water restriction was demonstrated in Figure 4. In con-
trast to rBSC1 expression, water restriction did not change
Fig. 3. Rat bumetanide sensitive cotransporter (rBSC) 1 protein signals
of rats with V2 receptor antagonist OPC-31260. (A ) Signal bands of
immunoblotting (100 g in each lane). (B ) Level of protein expression
determined by signal density. Data are mean SD of 6 determinations
in each condition. *P 0.05 compared to rats without water restriction.
Fig. 4. Aquaporin 2 (AQP2) expression. (A ) Immunoblotting of
AQP2. The amount of protein loaded in each lane is 100 g. (B )
Competitive polymerase chain reaction (PCR) of AQP2. Data represent
the mean  SD of 6 determinations in each condition. *P  0.05.
the expressional level of AQP2 protein (Fig. 4A). We
confirmed the markedly increased AQP2 protein in BB
rats with AVP infusion (data not shown). Competitive
PCR demonstrated the reduced AQP2 mRNA in rats
with water restriction (Fig. 4B).
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DISCUSSION
By using the BB rats we demonstrated the coincidence
of urinary concentration and enhancement of rBSC1 ex-
pression, but not of AQP2. Although the duration of
water restriction was only 4 hours, reduction in body
weight and significant elevation in plasma osmolality in-
dicated the physiologic condition of dehydration. Pro-
longed water restriction (24 hr) has been reported to
induce further elevation in urinary osmolality. Such pro-
longation, however, induces reduction in glomerular fil-
tration rate (GFR) [18]. Thus, we examined the BB rats
showing apparent physical signs of dehydration and unal-
tered level of plasma creatinine. Remarkable physiologic
findings in this setting were marked elevation in plasma
sodium, reduction in urinary sodium excretion, and sig-
nificant increased sodium and urea accumulations in the
renal medulla. Since rBSC1 expression was also en-
hanced in this condition, rBSC1 abundance might con-
tribute, at least in part, to a increase in renal sodium
absorption, supplying a driving force for water reabsorp-
tion and following urea transport in the collecting duct.
In contrast to rBSC1, the signal for AQP2 protein was
unaltered and RNA was decreased in dehydrated BB
rats. The association between expressional regulation of
AQP2 and urinary concentration has been well estab-
lished [4, 5, 21]. Thus, these observations indicate that
AQP2 expression had little influence on the urinary con-
centration in dehydrated BB rats. Together with physio-
logic presentation in rBSC1 abundance, sodium and urea
accumulation in the renal medulla, and elevated urine
osmolality, the present finding in AQP2 expression dem-
onstrates the strong evidence that rBSC1 expression ini-
tiates the countercurrent multiplication for urinary con-
centration. Loss of AQP2 abundance, on the contrary,
might limit the level of urinary concentration in dehy-
drated BB rats.
Kim et al [10] have demonstrated that endogenous
AVP administration induces marked rBSC1 abundance.
In the present study we confirmed the DDAVP-induced
abundance of rBSC1 in BB rats, which was more than
that induced by dehydration. On the other hand, Baer-
wolff and Bie [23] reported the presence of very low
plasma AVP still in BB rats. Thus, the AVP V2 antagonist
OPC-31260 was administered to other BB rats to com-
pletely block the effects of AVP. Interestingly, this drug
lowered urine osmolality as reported by Serradeil-Le
Gal et al [24]. Water restriction, however, concentrated
urine and increased rBSC1 expression even in these rats.
Since OPC-31260 would also block oxytocin access to
vasopressin receptors, this residual concentrating ability
cannot be attributed to oxytocin, which shows AVP ac-
tions in BB rats [19, 20]. Therefore, these present findings
indicate the presence of AVP-dependent and -indepen-
dent mechanisms for rBSC1 expression, both of which
may be independently involved in urinary concentration.
Although AVP, which induces both rBSC1 and AQP2
abundance [6, 7, 10], is the major regulator of urinary
concentration, DDAVP infusion alone failed to achieve
maximal urinary concentration. Accordingly, both mech-
anisms, AVP-dependent and AVP-independent, are
considered as minimal requirements for maximal urinary
concentration.
Recently Klein et al [15] reported the impaired urinary
concentration and reduced transporters including BSC1
on mice without tissue ACE activity. Since angiotensin
II infusion did not recover these abnormalities in their
settings, the influence of renin-angiotensin system on
BSC1 expression is still unclear. Another possibility is
the regulation by neural stimulus, since we found the
loss of maximal urinary concentration and further abun-
dance of rBSC1 in kidney isograft, a kidney with dener-
vation [12]. One or both of these factors are possibly
involved in the AVP-independent expression of BSC1.
Recently, Attmane-Elakeb et al [25] found that gluco-
corticoid stimulates rBSC1 expression by interactions
with hypertonicity and AVP or cyclic AMP (cAMP),
indicating the complex of AVP-dependent transcrip-
tional factors at the level of the promoters. Our present
study demonstrated the intensified rBSC1 mRNA in a rat
with AVP deficiency. Therefore, different factors may
regulate rBSC1 transcription independently, though lit-
tle is known about intracellular mechanisms of rBSC1
expression. In our previous study we examined a rat
model for Li nephropathy and indicated that enhanced
rBSC1 expression supplied the Li ions into the renal
medulla, which might reduce adenylase cyclase activity
in the collecting duct, inhibit AQP2 expression, and show
urinary concentrating defect [22]. The finding of en-
hanced rBSC1, both mRNA and protein, and reduced
AQP2 in this model also suggests that rBSC1 expression
in response to AVP stimuli is mediated, at least in part,
by the mechanism other than cAMP. Therefore, even
for the AVP dependency, multiple mechanisms may be
involved in rBSC1 transcription.
CONCLUSION
We have demonstrated strong evidence for the associ-
ation between rBSC1 expression and renal urinary con-
centration. Enhanced rBSC1 expression may directly
promote the countercurrent multiplication. We also found
that the rBSC1 expression is in part regulated by an
AVP-independent mechanism, which will be assessed in
our next study.
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